Guidelines on the investigation and management of antiphospholipid syndrome
Deepa J. Arachchillage(Imperial College Healthcare NHS Trust), Karen Breen(Guy's and St Thomas' NHS Foundation Trust), Peter Sommerville(Guy's and St Thomas' NHS Foundation Trust), Justin Chu(Oxford Fertility), Matthew C. Pickering(Imperial Valley College), Kieron Hickey(Sheffield Teaching Hospitals NHS Foundation Trust), Peter MacCallum(Queen Mary University of London), Sean Platton(The Royal Free Hospital)
Cited by 49
Related Papers
C3 glomerulopathy: consensus report
|Kidney International|2013|635
Functional definition and characterization of acute traumatic coagulopathy
|Critical Care Medicine|2011|524
The incidence and magnitude of fibrinolytic activation in trauma patients
|Journal of Thrombosis and Haemostasis|2012|481
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial
|The Lancet Haematology|2016|404
Whole-Body MRI Versus PET in Assessment of Multiple Myeloma Disease Activity
|American Journal of Roentgenology|2009|184